Anthem has no plans of backing away from its plan to buy Cigna in the face of federal opposition, and the Anthem CEO Joseph Swedish said that his company plans to “run out the litigation as long as it takes,” expecting a trial to begin around October.
The health insurer told analysts on July 26 that it is preparing to fight the government’s lawsuit to block its deal, and the company said its participation in the government’s health insurance exchanges may be at stake.
The U.S. Department of Justice sued on July 21 to block both Anthem’s deal and another proposed insurer combination, Aetna’s $34-billion purchase of Humana saying that the deals would reduce competition and raise prices on the exchanges and in other market segments.
These insurance mergers would reduce the nation’s five largest insurers to three.
Full Content: CNBC
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
DOJ and FTC Introduce Website for Reporting Anti-Competitive Healthcare Practices
Apr 18, 2024 by
CPI
US Congress Advances Legislation to Compel TikTok Sale
Apr 18, 2024 by
CPI
UK Financial Sector Advocates Enhanced Regulatory Accountability
Apr 18, 2024 by
CPI
Google and All 50 States Defend $700 Million Consumer Settlement
Apr 18, 2024 by
CPI
Colorado Enacts First Law to Protect Consumer Brainwave Data
Apr 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI